Skip to search formSkip to main contentSkip to account menu

NUDCD1 gene

Known as: NUDCD1, NUDC DOMAIN-CONTAINING PROTEIN 1, NudC domain containing 1 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Genes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
NudCD1 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells through the Activation of IGF1R-ERK1/2
Background: NudC domain containing 1 (NudCD1) is an oncoprotein related to diverse cancers. This study aims to investigate the… 
2018
2018
The impact of NudCD1 on renal carcinoma cell proliferation, migration, and invasion.
OBJECTIVE Renal cell carcinoma (RCC) is the most common malignant tumor in the urogenital system. Its easily metastatic… 
2017
2017
Protein interaction network of alternatively spliced NudCD1 isoforms
NudCD1, also known as CML66 or OVA66, is a protein initially identified as overexpressed in patients with chronic myelogenous… 
2014
2014
OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.
Ovarian cancer-associated antigen 66 (OVA66), also known as CML66 (GenBank Accession No. AF283301), was first identified in an… 
2009
2009
Graft-Versus-Leukemia Antigen CML66 Elicits Coordinated B and T Cell Immunity After Donor Lymphocyte Infusion.
Abstract 2449 Poster Board II-426 Donor lymphocyte infusion (DLI) is a highly effective treatment for relapsed chronic myeloid… 
2009
2009
Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A[*]2402-restricted cytotoxic T…
2008
2008
RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells.
2007
2007
Cytotoxic T-Lymphocyte Harnessing CML66 Can Kill Human Myeloid Leukemia Cells, In Vitro.
[Purpose & background] CML66 is a newly identified cancer-testis antigen by SEREX method in post-transplant CML patient who had a… 
Highly Cited
2005
Highly Cited
2005
Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells
Purpose: Donor lymphocyte infusion (DLI) reliably induces durable remission in 75% to 80% of patients with relapsed chronic… 
2003
2003
[Cloning, prokaryotic expression of CML66 and preparation of its polyclonal antibody].
AIM To clone and express CML66 cDNA and to prepare rabbit anti-CML66 antibody. METHODS cDNA isolated from the testis using RT… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)